Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-12

Clinical Trial Update: Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two PF-formulation eye drops for open-angle glaucoma and ocular hypertension; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eliptic Ofteno PF (Eliptic Ofteno PF)
  • Gaap Ofteno PF (Gaap Ofteno PF)
  • Krytantek Ofteno PF (Krytantek Ofteno PF)

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Status: TERMINATED